Eye and ENT: Eye inflammation, nasal/sinus congestion, sinus headache, throat irritation, inflammation of sinus, ear infection and pain. Central Nervous System : Headache, dizziness, sleep ...

ASTHMA sufferers have been told to check their inhalers after two brands have issued an urgent recall. Here’s what you need to know to work out if you need to pass your puffer back. Two brands have ...

A SMALL tear could help identify if your asthma inhaler is one of thousands recalled amid fears thousands are “putting sufferers’ lives at risk”. Two brands of inhalers have been found to be faulty, ...

LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...

The New England Journal of Medicine has published a clinical trial showing that Novartis' Ultibro Breezhaler outshone GlaxoSmithKline's Seretide on reducing COPD flare-ups, which could challenge the ...

Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting beta2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy[1],[2] ...

Mumbai: Glenmark Pharmaceuticals Ltd said on Friday that it has received regulatory approval for the generic version of GlaxoSmithKline Plc’s Seretide Accuhaler in the Nordic region, which includes ...

AN URGENT inhaler recall has been issued for asthma sufferers with GPs warning they are failing to deliver the correct doses of medication, putting people's lives "at risk". The Medicines and ...

The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...

A major pharmaceutical company which alleges trademark infringement has been refused an injunction preventing the roll-out by a rival of an inhaler for asthmatics. The injunction was sought pending ...